Amylyx Pharmaceuticals Inc (AMLX)
EBITDA Growth
-5.03%
Quarterly · Period ending:
AMLX EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-5.03%period ending
Latest reported-5.03%period ending
AMLX Quarterly EBITDA YoY % (-229.71% → -5.03%)
Year-over-year change
High-resolution chart · PNG
AMLX ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| -5.0312% | |
| -15.2024% | |
| 18.6002% | |
| 52.7255% | |
| 43.0254% | |
| 69.763% | |
| -661.03% | |
| -419.1256% | |
| -398.4684% | |
| -7,457.5607% | |
| 116.1576% | |
| 142.2835% | |
| 145.1551% | |
| 103.3713% | |
| -48.0934% | |
| -132.2151% | |
| -145.4728% | |
| -270.7186% | |
| -229.709% |